Video

ecancer's extensive video archive features interviews, panel discussions and conference coverage on almost every topic in oncology.
The cancer access partnership
Prof Richard Sullivan and Emily Kobayashi
The cancer access partnership ( Prof Richard Sullivan and Emily Kobayashi )
6 Oct 2022
The Max foundation: Its mission and contribution to increasing access to cancer ...
Prof Richard Sullivan and Pat Garcia-Gonzalez
The Max foundation: Its mission and contribution to increasing access to cancer medicine ( Prof Richard Sullivan and Pat Garcia-Gonzalez )
6 Oct 2022
Pursuing global equity in access to cancer drugs lessons learned from the HIV ep...
Prof Richard Sullivan and Dr Megan O’Brien
Pursuing global equity in access to cancer drugs lessons learned from the HIV epidemic ( Prof Richard Sullivan and Dr Megan O’Brien )
6 Oct 2022
Access to essential anticancer medicines for children and adolescents
Prof Richard Sullivan and Dr Carlos Rodriguez-Galindo
Access to essential anticancer medicines for children and adolescents ( Prof Richard Sullivan and Dr Carlos Rodriguez-Galindo )
6 Oct 2022
Cancer medicines on the WHO model list of essential medicines: processes, challe...
Prof Richard Sullivan and Dr André Ilbawi
Cancer medicines on the WHO model list of essential medicines: processes, challenges, and a way forward ( Prof Richard Sullivan and Dr André Ilbawi )
6 Oct 2022
ESMO 2022: Best approaches to bladder preservation
Prof Morgan Rouprêt and Prof Nick James
ESMO 2022: Best approaches to bladder preservation ( Prof Morgan Rouprêt and Prof Nick James )
27 Sep 2022
Xevinapant plus standard of care chemoradiotherapy improved 5 year OS for unrese...
Prof Jean Bourhis - University Hospital of Lausanne, Lausanne, Switzerland
Xevinapant plus standard of care chemoradiotherapy improved 5 year OS for unresected LA SCCHN ( Prof Jean Bourhis - University Hospital of Lausanne, Lausanne, Switzerland )
27 Sep 2022
Tislelizumab demonstrates non-inferior OS compared to sorafenib for treating hep...
Prof Masatoshi Kudo - Kindai University Faculty of Medicine, Osaka, Japan
Tislelizumab demonstrates non-inferior OS compared to sorafenib for treating hepatocellular carcinoma ( Prof Masatoshi Kudo - Kindai University Faculty of Medicine, Osaka, Japan )
26 Sep 2022
What is a clinical research? How to think about clinical research? Do you need t...
Prof Ian Tannock - Emeritus Professor of Medical Oncology, Princess Margaret Can...
What is a clinical research? How to think about clinical research? Do you need to do one? How do you do one ( Prof Ian Tannock - Emeritus Professor of Medical Oncology, Princess Margaret Cancer Centre, Toronto, Canada )
25 Sep 2022
Act Locally Think Globally: Sharing personal experiences of collaborating intern...
Dr Ramila Shilpakar - National Academy Of Medical Sciences, Bir Hospital, Kathma...
Act Locally Think Globally: Sharing personal experiences of collaborating internationally ( Dr Ramila Shilpakar - National Academy Of Medical Sciences, Bir Hospital, Kathmandu, Nepal )
25 Sep 2022
How to write a good peer-review?
Dr Ophira Ginsburg - Senior Scientific Officer, Senior Advisor for Clinical Rese...
How to write a good peer-review? ( Dr Ophira Ginsburg - Senior Scientific Officer, Senior Advisor for Clinical Research, U.S. National Cancer Institute- Center for Global Health, USA )
25 Sep 2022
How to develop and read clinical guidelines?
Dr Scott Berry - Queen's University, Kingston, Canada
How to develop and read clinical guidelines? ( Dr Scott Berry  - Queen's University, Kingston, Canada )
25 Sep 2022